Alx Oncology Holdings Inc [ALXO] stock prices are up 14.14% to $2.18 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ALXO shares have gain 16.58% over the last week, with a monthly amount glided 101.85%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Alx Oncology Holdings Inc [NASDAQ: ALXO] stock has seen the most recent analyst activity on March 06, 2025, when Jefferies upgraded its rating to a Buy and also boosted its price target to $3 from $2. Previously, Jefferies downgraded its rating to Hold on December 19, 2024, and dropped its price target to $2. On March 08, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $14 on the stock. Jefferies upgraded its rating to a Buy and increased its price target to $18 on December 08, 2023. Jefferies downgraded its rating to a Hold and reduced its price target to $25 on December 22, 2021. Stifel started tracking with a Buy rating for this stock on September 30, 2021, and assigned it a price target of $106.
The stock price of Alx Oncology Holdings Inc [ALXO] has been fluctuating between $0.40 and $2.05 over the past year. Currently, Wall Street analysts expect the stock to reach $21.38 within the next 12 months. Alx Oncology Holdings Inc [NASDAQ: ALXO] shares were valued at $2.18 at the most recent close of the market. An investor can expect a potential return of 880.73% based on the average ALXO price forecast.
Analyzing the ALXO fundamentals
Gross Profit Margin for this corporation currently stands at -0.22% with Operating Profit Margin at -140.15%, Pretax Profit Margin comes in at -134.3%, and Net Profit Margin reading is -134.3%. To continue investigating profitability, this company’s Return on Assets is posted at -1.22, Equity is -1.16 and Total Capital is -1.59. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.05.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.98 points at the first support level, and at 1.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.31, and for the 2nd resistance point, it is at 2.44.
Ratios To Look Out For
It’s worth pointing out that Alx Oncology Holdings Inc [NASDAQ:ALXO]’s Current Ratio is 4.52. Also, the Quick Ratio is 4.52, while the Cash Ratio stands at 1.02.
Transactions by insiders
Recent insider trading involved Lettmann Jason, CHIEF EXECUTIVE OFFICER, that happened on Sep 17 ’25 when 71163.0 shares were purchased. CHIEF EXECUTIVE OFFICER, Lettmann Jason completed a deal on Sep 16 ’25 to buy 21070.0 shares. Meanwhile, Chief Financial Officer Shantharam Harish bought 75000.0 shares on Aug 18 ’25.
